Evaluation of the interference of alkaloids obtained from the skin secretion of Ameerega picta in the penetration of rabies virus in BHK-21 cells
##plugins.themes.bootstrap3.article.main##
Resumo
Rabies is an infectious disease caused by a virus belonging to the family Lissavirus that affects all mammals including humans. Rabies transmission occurs by virus-containing saliva , through biting or licking of an injured tissue. The virus replicates at the site of inoculation until it reaches the nerve endings. At the neuromuscular junctions, the virus binds specifically to the nicotinic acetylcholine receptor. On the other hand, alkaloids have yielded interesting results in terms of drug development. Since rabies virus infection is, at least, partially associated to the nicotinic acetylcholine receptor, the present study focus on the evaluation of molecules obtained from the skin secretion of Ameerega picta, in the process of penetration and infection of rabies virus in Baby Hamster Kidney (BKK-21) cells. The secretion was collected though stimulation by manual compression of the amphibian glands, and then separated into 14 fractions by reversed-phase high performance liquid chromatography (RP-HPLC). The fractions were characterized by mass spectrometry and tested for their cytotoxic effect on BHK- 21 cells. Fraction 3 was the only one presenting cytotoxicity, by means of arising morphological changes when compared to the negative control (cells + MEM) and the positive control (cells + 20% DMSO). Subsequently, the fractions were screened for their ability to interfere in the process of virus cellular penetration. The rapid test for inhibition of fluorescent foci (RFFIT) showed that fractions 3, 6 and 7 were able to decrease the viral infection. Analyses by mass spectrometry showed that the molecules present in the active fractions ranged from 200 to 500 Da, which is in the alkaloid molecular mass range. Molecules are undergoing purification for proper virological assays and structural characterization.
##plugins.themes.bootstrap3.article.details##
1. Autores mantém os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho licenciado sob a Creative Commons Atribuição-NãoComercial-SemDerivações 4.0 Internacional
2. Autores têm autorização para assumir contratos adicionais separadamente, para distribuição não-exclusica da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.
3. Autores têm permissão e são estimulados a publicar e distribuir seu trabalho online (ex.: em repositórios instituicionais ou na sua página pessoal) a qualquer ponto antes ou durante o processo editorial, já que isso pode gerar alterações produtivas, bem como aumentar o impacto e a citação do trabalho publicado (Veja O Efeito do Acesso Livre);